Ohr Pharmaceutical (OHRP) Data from MAKO Study in Wet-AMD Did Not Meet Primary Efficacy Endpoint
Tweet Send to a Friend
Ohr Pharmaceutical, Inc. (NASDAQ: OHRP) today reported topline data from the MAKO study which did not meet its primary efficacy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
